Evidence map›Paper›PMID 29438992›Full record

ArticleMolecular & cellular proteomics : MCP2018

Nonlinear Regression Improves Accuracy of Characterization of Multiplexed Mass Spectrometric Assays.

Cyril Galitzine, Jarrett D Egertson, Susan Abbatiello, Clark M Henderson, Lindsay K Pino, Michael MacCoss, Andrew N Hoofnagle, Olga Vitek

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Improving Precursor Selectivity in Data-Independent Acquisition Using Overlapping Windows.Journal of the American Society for Mass Spectrometry · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cyril GalitzineFrom the ‡College of Science, Northeastern University, Boston, Massachusetts 02115.
Jarrett D Egertson§Department of Genome Sciences, University of Washington, Seattle, Washington 98195.
Susan Abbatiello¶Thermo Fisher Scientific, Cambridge, Massachusetts 02139.
Clark M Henderson‖Department of Laboratory Medicine, University of Washington, Seattle, Washington 98195.
Lindsay K Pino§Department of Genome Sciences, University of Washington, Seattle, Washington 98195.
Michael MacCoss§Department of Genome Sciences, University of Washington, Seattle, Washington 98195.
Andrew N Hoofnagle‖Department of Laboratory Medicine, University of Washington, Seattle, Washington 98195.
Olga VitekFrom the ‡College of Science, Northeastern University, Boston, Massachusetts 02115; o.vitek@neu.edu.

Funding

Nutrition, Obesity and Atherosclerosis Training ProgramT32HL007028 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1985 to 2026
$6.4M
NHLBI NIH HHS T32 HL007028
6 · The paper itself

Abstract

The need for assay characterization is ubiquitous in quantitative mass spectrometry-based proteomics. Among many assay characteristics, the limit of blank (LOB) and limit of detection (LOD) are two particularly useful figures of merit. LOB and LOD are determined by repeatedly quantifying the observed intensities of peptides in samples with known peptide concentrations and deriving an intensity

Indexed as

Nonlinear DynamicsAmino Acid SequenceBiological AssayCalibrationHumansLimit of DetectionMass SpectrometryModels, TheoreticalPeptidesRegression AnalysisPeptides

Identifiers

PMID29438992
PMCPMC5930407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.